Hepatitis C Virus Induces a Mutator Phenotype: Enhanced Mutations of Immunoglobulin and Protooncogenes
Overview
Authors
Affiliations
Hepatitis C virus (HCV) is a nonretroviral oncogenic RNA virus, which is frequently associated with hepatocellular carcinoma (HCC) and B cell lymphoma. We demonstrated here that acute and chronic HCV infection caused a 5- to 10-fold increase in mutation frequency in Ig heavy chain, BCL-6, p53, and beta-catenin genes of in vitro HCV-infected B cell lines and HCV-associated peripheral blood mononuclear cells, lymphomas, and HCCs. The nucleotide-substitution pattern of p53 and beta-catenin was different from that of Ig heavy chain in HCV-infected cells, suggesting two different mechanisms of mutation. In addition, the mutated protooncogenes were amplified in HCV-associated lymphomas and HCCs, but not in lymphomas of nonviral origin or HBV-associated HCC. HCV induced error-prone DNA polymerase zeta, polymerase iota, and activation-induced cytidine deaminase, which together, contributed to the enhancement of mutation frequency, as demonstrated by the RNA interference experiments. These results indicate that HCV induces a mutator phenotype and may transform cells by a hit-and-run mechanism. This finding provides a mechanism of oncogenesis for an RNA virus.
B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.
Weniger M, Seifert M, Kuppers R Methods Mol Biol. 2024; 2865:1-30.
PMID: 39424718 DOI: 10.1007/978-1-0716-4188-0_1.
Tani J, Masaki T, Oura K, Tadokoro T, Morishita A, Kobara H Microorganisms. 2024; 12(9).
PMID: 39338599 PMC: 11434491. DOI: 10.3390/microorganisms12091926.
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies.
Zhang W, Zeng M, Li Y, Yu L Biomark Res. 2024; 12(1):71.
PMID: 39075601 PMC: 11287861. DOI: 10.1186/s40364-024-00617-6.
Carcinogenic mechanisms of virus-associated lymphoma.
Zhang Y, Guo W, Zhan Z, Bai O Front Immunol. 2024; 15:1361009.
PMID: 38482011 PMC: 10932979. DOI: 10.3389/fimmu.2024.1361009.
SARS-CoV-2 and the DNA damage response.
Grand R J Gen Virol. 2023; 104(11).
PMID: 37948194 PMC: 10768691. DOI: 10.1099/jgv.0.001918.